SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-025468
Filing Date
2017-04-24
Accepted
2017-04-24 16:32:37
Documents
7
Period of Report
2017-04-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-11684_18k.htm 8-K 35202
2 EX-1.1 a17-11684_1ex1d1.htm EX-1.1 211767
3 EX-5.1 a17-11684_1ex5d1.htm EX-5.1 10217
4 EX-99.1 a17-11684_1ex99d1.htm EX-99.1 11343
5 GRAPHIC g116841kei001.gif GRAPHIC 4139
6 GRAPHIC g116841kei002.gif GRAPHIC 1053
7 GRAPHIC g116841kei003.gif GRAPHIC 1035
  Complete submission text file 0001104659-17-025468.txt   278801
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 17778571
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1